Microtubules and microfilaments participate in the inhibition of synaptosomal noradrenaline release by tetanus toxin.
Tetanus toxin (TeTX) has been demonstrated to inhibit transmitter release by two mechanisms: Zn(2+)-dependent proteolytic cleavage of synaptobrevin and activation of a neuronal transglutaminase. Herein, attenuation of TeTX-induced blockade of noradrenaline release from synaptosomes was achieved by prior disassembly of microfilaments with cytochalasin D or breakdown of microtubules by colchicine or nocodazole. These drugs and monodansylcadaverine, a transglutaminase inhibitor, displayed some additivity in antagonizing the inhibitory effect of the toxin on synaptosomal transmitter release; as none of them reduced synaptobrevin cleavage, all appear to work independently of the toxin's proteolytic action. Prior stabilization of microtubules with taxol prevented the antagonism seen with colchicine, highlighting that this cytoskeletal component is the locus of the effect of colchicine. Replacement of Ca2+ with Ba2+ caused disappearance of the fraction of evoked secretion whose inhibition by TeTX is reliant on polymerized actin but did not alter the blockade by toxin that is dependent on microtubules. Two temporally distinguished phases of release were reduced by TeTX, and colchicine lessened its effects on both. Blockade of the fast phase (< or = 10 s) of secretion by TeTX was unaffected by cytochalasin D, but it clearly antagonized the toxin-induced inhibition of the slow (10-s to > or = 5-min) component; it is notable that such antagonism was accentuated during a second bout of evoked release. These findings are consistent with sustained release requiring dissociation of synaptic vesicles from the microfilaments, a step that seems to be perturbed by TeTX.
Ashton
A C
AC
Department of Biochemistry, Imperial College, London, England.
Dolly
J O
JO
D008841:Actin Cytoskeleton / Q000378:metabolism*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D001464:Barium / Q000494:pharmacology; D002103:Cadaverine / Q000031:analogs & derivatives / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002540:Cerebral Cortex / Q000737:chemistry; D003078:Colchicine / Q000494:pharmacology; D015638:Cytochalasin D / Q000494:pharmacology; D003599:Cytoskeleton / Q000378:metabolism; D010450:Endopeptidases; D004734:Energy Metabolism / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006074:Gout Suppressants / Q000494:pharmacology; D008565:Membrane Proteins / Q000378:metabolism; D008870:Microtubules / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D015739:Nocodazole / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D017239:Paclitaxel / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D050683:R-SNARE Proteins; D051381:Rats; D013572:Synaptic Vesicles / Q000737:chemistry / Q000201:enzymology / Q000378:metabolism; D013574:Synaptosomes / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D013744:Tetanus Toxin / Q000494:pharmacology*; D011503:Transglutaminases / Q000378:metabolism
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D004791:Enzyme Inhibitors; D006074:Gout Suppressants; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D019384:Nucleic Acid Synthesis Inhibitors; D050683:R-SNARE Proteins; D013744:Tetanus Toxin; D015638:Cytochalasin D; D001464:Barium; D011503:Transglutaminases; D010450:Endopeptidases; C008542:monodansylcadaverine; D002103:Cadaverine; D017239:Paclitaxel; D011188:Potassium; D015739:Nocodazole; D003078:Colchicine; D002118:Calcium; D009638:Norepinephrine